Point-of-care Glucose Monitoring in COVID-19 Intensive Care Unit: How's It Different?
Citation Information :
Point-of-care Glucose Monitoring in COVID-19 Intensive Care Unit: How's It Different?. Indian J Crit Care Med 2021; 25 (12):1465-1466.
Johnson KD, Harris C, Cain JK, Hummer C, Goyal H, Perisetti A. Pulmonary and extra-pulmonary clinical manifestations of COVID-19. Front Med (Lausanne) 2020;7:526. DOI: 10.3389/fmed.2020.00526.
Sosale A, Sosale B, Kesavadev J, Chawla M, Reddy S, Saboo B, et al. Steroid use during COVID-19 infection and hyperglycemia–what a physician should know. Diabetes Metab Syndr 2021;15(4):102167. DOI: 10.1016/j.dsx.2021.06.004.
Ginsberg BH. Factors affecting blood glucose monitoring: sources of errors in measurement. J Diabetes Sci Technol 2009;3(4):903–913. DOI: 10.1177/193229680900300438.
Öberg D, Ostenson CG. Performance of glucose dehydrogenase–and glucose oxidase–based blood glucose meters at high altitude and low temperature. Diabetes Care 2005;28(5):1261. DOI: 10.2337/diacare.28.5.1261.
Ferri S, Kojima K, Sode K. Review of glucose oxidases and glucose dehydrogenases: a bird's eye view of glucose sensing enzymes. J Diabetes Sci Technol 2011;5(5):1068–1076. DOI: 10.1177/193229681100500507.
